Law360 (April 19, 2018, 8:03 PM EDT) — Amneal Pharmaceuticals urged the Federal Circuit on Wednesday to deny Merck & Co.’s request for reconsideration, or full rehearing, of a panel’s decision affirming that a generic nasal spray Amneal sells doesn’t infringe one of Merck’s patents, contesting the …
